Trial Profile
An Open, Uncontrolled Study Investigating the Safety and Efficacy of GK567 in the Deodorization of Malodorous Infected Cutaneous Fungating Neoplastic Tumours, Over 14 Days of Treatment
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Metronidazole (Primary)
- Indications Skin infections; Skin ulcer
- Focus Therapeutic Use
- Sponsors Galderma
- 11 Apr 2014 New trial record